Search

Your search keyword '"Chavannes, N."' showing total 554 results

Search Constraints

Start Over You searched for: Author "Chavannes, N." Remove constraint Author: "Chavannes, N."
554 results on '"Chavannes, N."'

Search Results

207. NHG-Standaard COPD.

208. NHG-Standaard Astma bij volwassenen.

212. Parallelization of the FDTD method based on the open computing language and the message passing interface.

214. COMPARISON OF CPML IMPLEMENTATIONS FOR THE GPU-ACCELERATED FDTD SOLVER.

215. Het nut van de orale prednisontest bij de behandeling van COPD in de eerste lijn.

216. Which clinical signs and symptoms predict hypoxemia in acute childhood asthma?

217. Which clinical signs and symptoms predict hypoxemia in acute childhood asthma?

222. Reduced glucose consumption in the curly tail mouse does not initiate the pathogenesis leading to spinal neural tube defects.

223. Zelfmanagement van COPD: welke patiënt heeft er baat bij?

224. The enduring effects of adverse childhood experiences (ACES) on mood dysregulation in children: A literature review.

226. COPD’s early origins in low-and-middle income countries: what are the implications of a false start?

227. "It's on everyone's plate": a qualitative study into physicians' perceptions of responsibility for smoking cessation.

229. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

230. Effectiviteit van de ‘Ziektelastmeter COPD’

231. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

236. Facilitating smoking cessation in patients who smoke: a large-scale cross-sectional comparison of fourteen groups of healthcare providers.

237. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD).

239. Work productivity in rhinitis using cell phones: The MASK pilot study.

240. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

241. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. a MASK study

242. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

243. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

244. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases: Review

245. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

246. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

247. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

248. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

249. Treatment of allergic rhinitis using mobile technology with real world data: The MASK observational pilot study

250. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

Catalog

Books, media, physical & digital resources